Abcellera Biologics Correlations
| ABCL Stock | USD 3.74 0.03 0.80% |
The current 90-days correlation between Abcellera Biologics and Celldex Therapeutics is 0.31 (i.e., Weak diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Abcellera Biologics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Abcellera Biologics moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
Abcellera Biologics Correlation With Market
Weak diversification
The correlation between Abcellera Biologics and DJI is 0.35 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Abcellera Biologics and DJI in the same portfolio, assuming nothing else is changed.
Abcellera | Build AI portfolio with Abcellera Stock |
Moving together with Abcellera Stock
| 0.65 | MAIA | MAIA Biotechnology | PairCorr |
| 0.61 | ABSI | Absci Corp Upward Rally | PairCorr |
| 0.81 | ALVO | Alvotech | PairCorr |
Moving against Abcellera Stock
| 0.75 | PTN | Palatin Technologies Trending | PairCorr |
| 0.69 | NAUT | Nautilus Biotechnology | PairCorr |
| 0.54 | ESPR | Esperion Therapeutics | PairCorr |
| 0.5 | 600201 | Jinyu Bio Technology | PairCorr |
| 0.49 | GILD | Gilead Sciences | PairCorr |
| 0.35 | 300439 | Ningbo MedicalSystem | PairCorr |
| 0.8 | 688670 | Jiangsu GDK Biotechnology | PairCorr |
| 0.68 | AMGN | Amgen Inc | PairCorr |
| 0.62 | ABDX | Abingdon Health Plc | PairCorr |
| 0.58 | CIZ | Cizzle Biotechnology | PairCorr |
| 0.83 | EC | Ecopetrol SA ADR | PairCorr |
| 0.83 | TLK | Telkom Indonesia Tbk | PairCorr |
| 0.79 | CTMCF | Canterra Minerals | PairCorr |
| 0.74 | OOAG | OMDA Oil | PairCorr |
| 0.71 | KB | KB Financial Group | PairCorr |
| 0.57 | PFG | Principal Financial | PairCorr |
Related Correlations Analysis
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Abcellera Stock performing well and Abcellera Biologics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Abcellera Biologics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| CLDX | 2.35 | 0.16 | 0.06 | 0.17 | 2.74 | 5.97 | 13.45 | |||
| VERA | 3.17 | 0.78 | 0.26 | 0.37 | 2.87 | 10.77 | 23.44 | |||
| JANX | 4.09 | (0.15) | 0.00 | 0.16 | 0.00 | 9.48 | 63.52 | |||
| SYRE | 3.62 | 1.04 | 0.31 | 0.48 | 2.87 | 10.99 | 29.33 | |||
| BHVN | 4.63 | (0.22) | 0.00 | (0.24) | 0.00 | 9.97 | 52.54 | |||
| SION | 3.24 | 0.83 | 0.24 | 0.72 | 3.00 | 7.92 | 42.57 | |||
| IMNM | 4.21 | 1.18 | 0.33 | 0.58 | 3.31 | 13.34 | 25.75 | |||
| PHVS | 3.17 | 0.31 | 0.05 | (0.24) | 3.48 | 8.92 | 27.49 | |||
| XERS | 2.50 | (0.15) | 0.00 | (0.06) | 0.00 | 4.23 | 36.05 | |||
| NUVB | 4.38 | 1.63 | 0.38 | (0.75) | 2.94 | 12.05 | 54.16 |
Abcellera Biologics Corporate Management
| Andy Clark | Head Assurance | Profile | |
| Veronique Lecault | COO Director | Profile | |
| Bo Barnhart | Scientific Director | Profile | |
| Andrew MBA | Chief Officer | Profile | |
| EdD CEC | Senior Development | Profile | |
| Paul Colussi | Site Technologies | Profile | |
| JD Esq | Chief Officer | Profile |